• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1H-1,2,3-三唑-1-基硫代半乳糖苷衍生物作为高亲和力半乳糖凝集素-3 抑制剂。

1H-1,2,3-triazol-1-yl thiodigalactoside derivatives as high affinity galectin-3 inhibitors.

机构信息

Chemistry Department, The Hashemite University, PO Box 150459, Zarka 13115, Jordan.

出版信息

Bioorg Med Chem. 2010 Jul 15;18(14):5367-78. doi: 10.1016/j.bmc.2010.05.040. Epub 2010 May 20.

DOI:10.1016/j.bmc.2010.05.040
PMID:20538469
Abstract

Galactose C3-triazole derivatives were synthesized by Cu(I)-catalyzed cycloaddition between acetylenes and galactose C3-azido derivatives. Evaluation against galectin-3, 7, 8N (N-terminal) and 9N (N-terminal) revealed 1,4-disubstituted triazoles to be high-affinity inhibitors of galectin-3 with selectivity over galectin-7, 8N, and 9N. Conformational analysis of 1,4-di- and 1,4,5-tri-substituted galactose C3-triazoles suggested that a triazole C5-substituent interfered sterically with the galectin proteins, which explained their poor affinities compared to the corresponding 1,4-disubstituted triazoles. Introduction of two 1,4-disubstituted triazole moieties onto thiodigalactoside resulted in affinities down to 29 nM for galectin-3.

摘要

半乳糖 C3-三唑衍生物通过铜(I)催化的炔烃和半乳糖 C3-叠氮衍生物之间的环加成反应合成。对半乳糖凝集素-3、7、8N(N 端)和 9N(N 端)的评估表明,1,4-二取代三唑是半乳糖凝集素-3 的高亲和力抑制剂,对半乳糖凝集素-7、8N 和 9N 具有选择性。1,4-二取代和 1,4,5-三取代半乳糖 C3-三唑的构象分析表明,三唑 C5-取代基在空间上与半乳糖蛋白相互干扰,这解释了它们与相应的 1,4-二取代三唑相比亲和力较差。在硫代半乳糖苷上引入两个 1,4-二取代三唑部分,导致对半乳糖凝集素-3 的亲和力低至 29 nM。

相似文献

1
1H-1,2,3-triazol-1-yl thiodigalactoside derivatives as high affinity galectin-3 inhibitors.1H-1,2,3-三唑-1-基硫代半乳糖苷衍生物作为高亲和力半乳糖凝集素-3 抑制剂。
Bioorg Med Chem. 2010 Jul 15;18(14):5367-78. doi: 10.1016/j.bmc.2010.05.040. Epub 2010 May 20.
2
Synthesis of galactose-mimicking 1H-(1,2,3-triazol-1-yl)-mannosides as selective galectin-3 and 9N inhibitors.半乳糖模拟的1H-(1,2,3-三唑-1-基)甘露糖苷作为选择性半乳糖凝集素-3和9N抑制剂的合成。
Carbohydr Res. 2007 Sep 3;342(12-13):1869-75. doi: 10.1016/j.carres.2007.03.012. Epub 2007 Mar 14.
3
Tuning the preference of thiodigalactoside- and lactosamine-based ligands to galectin-3 over galectin-1.调节硫代二半乳糖苷和乳糖胺基配体对半乳糖凝集素-3相对于半乳糖凝集素-1的偏好性。
J Med Chem. 2013 Feb 14;56(3):1350-4. doi: 10.1021/jm301677r. Epub 2013 Jan 23.
4
Fragment-based development of triazole-substituted O-galactosyl aldoximes with fragment-induced affinity and selectivity for galectin-3.基于片段的三唑取代的O-半乳糖基醛肟的开发,具有片段诱导的对半乳糖凝集素-3的亲和力和选择性。
Org Biomol Chem. 2009 Oct 7;7(19):3982-90. doi: 10.1039/b909091f. Epub 2009 Jul 20.
5
Synthesis and evaluation of new thiodigalactoside-based chemical probes to label galectin-3.用于标记半乳糖凝集素-3的新型硫代二半乳糖苷基化学探针的合成与评价
Chembiochem. 2009 Jul 6;10(10):1724-33. doi: 10.1002/cbic.200900198.
6
3-(1,2,3-Triazol-1-yl)-1-thio-galactosides as small, efficient, and hydrolytically stable inhibitors of galectin-3.3-(1,2,3-三唑-1-基)-1-硫代半乳糖苷作为半乳糖凝集素-3的小型、高效且水解稳定的抑制剂。
Bioorg Med Chem Lett. 2005 Jul 15;15(14):3344-6. doi: 10.1016/j.bmcl.2005.05.084.
7
C2-symmetrical thiodigalactoside bis-benzamido derivatives as high-affinity inhibitors of galectin-3: efficient lectin inhibition through double arginine-arene interactions.作为半乳糖凝集素-3高亲和力抑制剂的C2对称硫代二半乳糖苷双苯甲酰胺衍生物:通过双精氨酸-芳烃相互作用实现高效的凝集素抑制作用
Angew Chem Int Ed Engl. 2005 Aug 12;44(32):5110-2. doi: 10.1002/anie.200500627.
8
A Selective Galactose-Coumarin-Derived Galectin-3 Inhibitor Demonstrates Involvement of Galectin-3-glycan Interactions in a Pulmonary Fibrosis Model.一种选择性半乳糖-香豆素衍生的半乳凝素-3抑制剂表明在肺纤维化模型中半乳凝素-3与聚糖的相互作用。
J Med Chem. 2016 Sep 8;59(17):8141-7. doi: 10.1021/acs.jmedchem.6b00957. Epub 2016 Aug 23.
9
Systematic Tuning of Fluoro-galectin-3 Interactions Provides Thiodigalactoside Derivatives with Single-Digit nM Affinity and High Selectivity.系统调控氟代半乳糖凝集素 3 的相互作用提供了硫代二半乳糖苷衍生物,其具有个位数纳摩尔亲和力和高选择性。
J Med Chem. 2018 Feb 8;61(3):1164-1175. doi: 10.1021/acs.jmedchem.7b01626. Epub 2018 Jan 11.
10
Efficient synthesis of a galectin inhibitor clinical candidate (TD139) using a Payne rearrangement/azidation reaction cascade.利用Payne 重排/叠氮化反应级联反应高效合成半乳糖凝集素抑制剂临床候选药物(TD139)。
Org Biomol Chem. 2020 May 27;18(20):3903-3907. doi: 10.1039/d0ob00910e.

引用本文的文献

1
Synergy of triazolyl substituents at C1 and C3 of galactose for high-affinity and selective galectin-4C inhibition.半乳糖C1和C3位三唑基取代基对高亲和力和选择性半乳糖凝集素-4C抑制的协同作用。
RSC Chem Biol. 2025 Jul 18. doi: 10.1039/d5cb00106d.
2
Growth factor-triggered de-sialylation controls glycolipid-lectin-driven endocytosis.生长因子触发的去唾液酸化作用控制糖脂-凝集素驱动的内吞作用。
Nat Cell Biol. 2025 Mar;27(3):449-463. doi: 10.1038/s41556-025-01616-x. Epub 2025 Feb 21.
3
Exploration into Galectin-3 Driven Endocytosis and Lattices.
Galectin-3 驱动的内吞作用与晶格的探索。
Biomolecules. 2024 Sep 18;14(9):1169. doi: 10.3390/biom14091169.
4
Determining the Affinity and Kinetics of Small Molecule Inhibitors of Galectin-1 Using Surface Plasmon Resonance.使用表面等离子体共振测定半乳糖凝集素-1小分子抑制剂的亲和力和动力学。
Int J Mol Sci. 2024 Jun 18;25(12):6704. doi: 10.3390/ijms25126704.
5
Galectin-3 impairs calcium transients and β-cell function.半乳糖凝集素-3 损害钙瞬变和β细胞功能。
Nat Commun. 2024 May 1;15(1):3682. doi: 10.1038/s41467-024-47959-1.
6
Saturation Transfer Difference NMR and Molecular Docking Interaction Study of Aralkyl-Thiodigalactosides as Potential Inhibitors of the Human-Galectin-3 Protein.饱和转移差异 NMR 与烷基硫代半乳糖苷作为人半乳糖凝集素-3 蛋白潜在抑制剂的分子对接相互作用研究。
Int J Mol Sci. 2024 Feb 1;25(3):1742. doi: 10.3390/ijms25031742.
7
Discovery of -Arylsulfonyl-Indole-2-Carboxamide Derivatives as Galectin-3 and Galectin-8 C-Terminal Domain Inhibitors.发现 -芳基磺酰基-吲哚-2-甲酰胺衍生物作为半乳糖凝集素-3和半乳糖凝集素-8 C末端结构域抑制剂
ACS Med Chem Lett. 2023 Aug 15;14(9):1257-1265. doi: 10.1021/acsmedchemlett.3c00261. eCollection 2023 Sep 14.
8
Glycomimetics for the inhibition and modulation of lectins.糖基模拟物抑制和调节凝集素。
Chem Soc Rev. 2023 Jun 6;52(11):3663-3740. doi: 10.1039/d2cs00954d.
9
Targeting galectin-driven regulatory circuits in cancer and fibrosis.靶向癌症和纤维化中半乳糖凝集素驱动的调控通路
Nat Rev Drug Discov. 2023 Apr;22(4):295-316. doi: 10.1038/s41573-023-00636-2. Epub 2023 Feb 9.
10
Inhibition of galectins in cancer: Biological challenges for their clinical application.抑制癌症中的半乳糖凝集素:其临床应用的生物学挑战。
Front Immunol. 2023 Jan 10;13:1104625. doi: 10.3389/fimmu.2022.1104625. eCollection 2022.